Whistleblower Suits Alleging Off-label Promotion Need Not Be Specific – Gov’t
Executive Summary
The U.S. government says whistleblowers do not need to provide specific details of misconduct in claiming a company marketed a drug for an unapproved use
You may also be interested in...
Whistleblower Must Show Pfizer Provided Kickbacks In Off-Label Promotion
A former Pharmacia & Upjohn executive may proceed with his off-label promotion suit against Pfizer, but he must show the company engaged in unlawful kickbacks, a federal judge ruled
Whistleblower Must Show Pfizer Provided Kickbacks In Off-Label Promotion
A former Pharmacia & Upjohn executive may proceed with his off-label promotion suit against Pfizer, but he must show the company engaged in unlawful kickbacks, a federal judge ruled
False Claims Act Suits May Become Harder After Supreme Court Ruling
A U.S. Supreme Court ruling restricts when whistleblowers can sue someone for fraud against the government. But the opinion is limited to certain situations and may not affect suits brought against drug companies